Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD11 | O00231 | 1/20 | 0.55 |
| ▸ | BRD4 | O60885 | 1/20 | 0.51 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.51 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.50 |
| ▸ | QPCT | Q16769 | 9/20 | 0.49 |
| ▸ | QPCTL | Q9NXS2 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | PRKCI | P41743 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2457410 | 0.87 | PSMD11 (0.42) | PSMD11BRD4CREBBPS1PR1QPCT | |
| SCHEMBL8634290 | 0.78 | QPCT (0.68) | PSMD11BRD4CREBBPQPCTQPCTL | |
| SCHEMBL2458235 | 0.76 | PSMD11 (0.53) | PSMD11BRD4CREBBPS1PR1QPCT | |
| SCHEMBL2459898 | 0.75 | BRD4 (0.52) | PSMD11BRD4CREBBPS1PR1QPCT | |
| SCHEMBL2463860 | 0.74 | BRD4 (0.49) | BRD4S1PR1KDM4EALDH1A1HPGD | |
| SCHEMBL16307909 | 0.74 | RAB9A (0.50) | KDM4ENPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL29458961 | 0.73 | QPCT (0.54) | BRD4CREBBPQPCTQPCTLKDM4E | |
| SCHEMBL2474515 | 0.72 | QPCT (0.60) | PSMD11BRD4CREBBPQPCTQPCTL | |
| SCHEMBL2457603 | 0.71 | QPCT (0.51) | PSMD11BRD4CREBBPQPCTQPCTL | |
| SCHEMBL2459263 | 0.71 | QPCT (0.51) | PSMD11BRD4CREBBPS1PR1QPCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110237633-A1 | SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2011-09-29 | — | — | US | disclosed |
| WO-2010068287-A2 | SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | ANGION BIOMEDICA CORP. (US) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237633-A1 | SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | HGF, HDGF, MET | PSMD11 4096/4885BRD4 3654/4885CREBBP 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.